/**
 * Quick Review content for Topic 26 - Respiratory mechanics 2: Ventilation
 * Auto-generated by Quick Review Generator
 */
const topic26QuickReview = {
  topicId: 'topic-26',
  topicNumber: 26,
  learningObjectives: {
    'lo-1': {
      title: 'Draw a diagram showing how pleural pressure, alveolar pressure, air flow, and lung volume changes during the respiratory cycle. Indicate the beginning and the end of inspiration, and the end of expiration. Describe how the pressure gradient between intrapulmonal and atmospheric pressure drives air movement in and out of the lung.',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'Respiratory Cycle Pressure Changes' },
        { type: 'steps', intro: 'At Rest (End of Expiration):', items: [
          'Lungs at FRC (functional residual capacity)',
          'Pleural pressure: -5 cmH₂O',
          'Alveolar pressure: 0 cmH₂O (equals atmospheric)',
          'No airflow (no pressure gradient)'
        ]},
        { type: 'steps', intro: 'During Inspiration:', items: [
          'Diaphragm contracts, thoracic cavity expands',
          'Pleural pressure: -5 → -8 cmH₂O (more negative)',
          'Alveolar pressure: drops to -1 cmH₂O',
          'Pressure gradient drives air IN (peak flow: -0.5 L/s)',
          'Lung volume increases'
        ]},
        { type: 'steps', intro: 'End of Inspiration:', items: [
          'Diaphragm stops expanding',
          'Pleural pressure: stabilizes at -8 cmH₂O',
          'Alveolar pressure: returns to 0 cmH₂O',
          'No airflow (brief transition moment)',
          'Lung volume at maximum'
        ]},
        { type: 'steps', intro: 'During Expiration (Passive):', items: [
          'Diaphragm relaxes, elastic recoil compresses lungs',
          'Pleural pressure: -8 → -5 cmH₂O (less negative)',
          'Alveolar pressure: rises to +1 cmH₂O',
          'Pressure gradient drives air OUT (peak flow: +0.5 L/s)',
          'Lung volume decreases'
        ]},
        { type: 'steps', intro: 'End of Expiration:', items: [
          'Returns to FRC',
          'Pleural pressure: -5 cmH₂O',
          'Alveolar pressure: 0 cmH₂O',
          'No pressure gradient, no airflow',
          'Ready for next cycle'
        ]},
        { type: 'keypoint', text: 'Fundamental Principle: Air flows from high to low pressure. Inspiration = alveolar < atmospheric. Expiration = alveolar > atmospheric.' }
      ]
    },
    'lo-2': {
      title: '>>Describe the factors constituting dynamic lung resistance against lung volume changes<< (airway resistance and viscous tissue resistance). Describe based on the segmental differences in individual airway diameters, total cross sectional area of parallel coupled airways, and the occurrence of turbulent as well as laminar flow, WHY the upper airways and the great bronchi contribute principally to airway resistance.',
      isCritical: true,
      blocks: [
        { type: 'header', text: 'Dynamic Lung Resistance Components', critical: true },
        { type: 'comparison',
          left: {
            title: 'Airway Resistance (Raw)',
            items: [
              'Opposition to airflow in respiratory passages',
              'Determined by airway diameter (R ∝ 1/r⁴)',
              'Affected by lung volume',
              'Depends on flow type (turbulent vs laminar)',
              '~80% occurs in upper airways'
            ]
          },
          right: {
            title: 'Viscous Tissue Resistance',
            items: [
              'Frictional resistance of lung tissue',
              'Chest wall moving against structures',
              'Due to viscoelastic properties',
              'Pleural surface interaction',
              'Increases during expansion'
            ]
          }
        },
        { type: 'header', text: 'Why Upper Airways Dominate Resistance', critical: true },
        { type: 'list', intro: 'Upper airways (trachea, bronchi) contribute most resistance despite larger individual diameters:', items: [
          'Low total cross-sectional area (limited parallel pathways)',
          'High airflow velocity concentrated in fewer passages',
          'Turbulent flow (high Reynolds number)',
          'Irregular surfaces increase friction'
        ]},
        { type: 'list', intro: 'Smaller airways (bronchioles) contribute less resistance:', items: [
          'Enormous total cross-sectional area (vast number in parallel)',
          'Dramatically reduced velocity',
          'Laminar flow (low friction)',
          'Despite narrow individual diameters'
        ]},
        { type: 'comparison',
          left: {
            title: 'Turbulent Flow (Upper Airways)',
            items: [
              'High velocity',
              'Large diameter',
              'High Reynolds number',
              'Much greater resistance',
              'Inefficient airflow'
            ]
          },
          right: {
            title: 'Laminar Flow (Small Airways)',
            items: [
              'Low velocity',
              'Many parallel pathways',
              'Low Reynolds number',
              'Minimal resistance',
              'Smooth airflow'
            ]
          }
        },
        { type: 'keypoint', text: 'Poiseuille Law: Resistance ∝ 1/r⁴. Even small changes in airway diameter cause large resistance changes.', critical: true },
        { type: 'clinical', text: 'Clinical: Bronchoconstriction in asthma/COPD increases resistance. Higher lung volumes reduce resistance by stretching airways open.' }
      ]
    },
    'lo-3': {
      title: '>>Define and explain the following terms: anatomic and physiologic dead space, respiratory rate, respiratory minute volume, dead space ventilation, alveolar ventilation.<<',
      isCritical: true,
      blocks: [
        { type: 'header', text: 'Dead Space Definitions', critical: true },
        { type: 'comparison',
          left: {
            title: 'Anatomic Dead Space',
            items: [
              'Conducting airways (nose, trachea, bronchi)',
              'NO gas exchange occurs',
              'Volume: ~150 mL',
              'Fixed structural component'
            ]
          },
          right: {
            title: 'Physiologic Dead Space',
            items: [
              'All air NOT participating in gas exchange',
              'Anatomic dead space PLUS non-perfused alveoli',
              'In healthy: equals anatomic dead space',
              'Increases in pulmonary embolism, emphysema'
            ]
          }
        },
        { type: 'header', text: 'Ventilation Parameters', critical: true },
        { type: 'table', headers: ['Parameter', 'Definition', 'Normal Value'], rows: [
          ['Respiratory Rate', 'Breaths per minute', '14 breaths/min'],
          ['Tidal Volume (VT)', 'Volume per breath', '500 mL'],
          ['Anatomic Dead Space (VD)', 'Conducting airway volume', '150 mL'],
          ['Minute Ventilation', 'VT × RR', '7 L/min'],
          ['Dead Space Ventilation', 'VD × RR', '2.1 L/min'],
          ['Alveolar Ventilation', '(VT - VD) × RR', '5 L/min']
        ]},
        { type: 'formula', formula: 'Minute Ventilation = Tidal Volume × Respiratory Rate', explanation: 'Total air moving in/out per minute (VT × RR)', critical: true },
        { type: 'formula', formula: 'Alveolar Ventilation = (VT - VD) × RR', explanation: 'Fresh air reaching alveoli for gas exchange per minute', critical: true },
        { type: 'formula', formula: 'Dead Space Ventilation = VD × RR', explanation: 'Air ventilating dead space per minute', critical: true },
        { type: 'keypoint', text: 'Alveolar ventilation is the MOST IMPORTANT measure - it determines actual gas exchange capacity, not minute ventilation!', critical: true },
        { type: 'clinical', text: 'Clinical: Shallow rapid breathing increases dead space ventilation relative to alveolar ventilation. Deep slow breathing is more efficient.' }
      ]
    },
    'lo-4': {
      title: 'Describe the method to determine physiologic dead space.',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'Bohr Method for Physiologic Dead Space' },
        { type: 'formula', formula: 'VD/VT = (PaCO₂ - PECO₂) / PaCO₂', explanation: 'Bohr Equation: Ratio of dead space to tidal volume', critical: false },
        { type: 'table', headers: ['Variable', 'Meaning', 'How Measured'], rows: [
          ['VD', 'Dead space volume', 'Calculated from equation'],
          ['VT', 'Tidal volume', 'Spirometry'],
          ['PaCO₂', 'Arterial CO₂ partial pressure', 'Arterial blood gas'],
          ['PECO₂', 'Mixed expired CO₂', 'Expired air collection']
        ]},
        { type: 'steps', intro: 'Measurement Procedure:', items: [
          'Obtain arterial blood via arterial puncture',
          'Measure PaCO₂ using blood gas analyzer',
          'Collect expired air over several breaths',
          'Analyze mixed expired air for PECO₂',
          'Substitute values into Bohr equation',
          'Calculate VD/VT ratio, then determine VD'
        ]},
        { type: 'paragraph', text: 'Physiological Principle: Alveolar CO₂ equals arterial CO₂ (equilibrium). Dead space air contains essentially no CO₂. Therefore, the difference between arterial and mixed expired CO₂ reflects the proportion of dead space.' },
        { type: 'keypoint', text: 'Normal VD/VT ratio: 0.2-0.35 (20-35% of tidal volume is dead space)' },
        { type: 'clinical', text: 'Clinical: Increased dead space suggests ventilated but non-perfused lung areas (pulmonary embolism, emphysema, V/Q mismatch)' }
      ]
    },
    'lo-5': {
      title: '>>Draw a spirogram of a forced expiratory effort.<< Indicate the forced vital capacity (FVC), the forced expiratory volume in 1 second >>(FEV1). Define the Tiffeneau-index<< (FEV1/VC). Define peak expiratory flow (PEF), and forced expiratory flow 25-75 (FEF25-75; between 25 and 75% of FVC).',
      isCritical: true,
      blocks: [
        { type: 'header', text: 'Forced Spirometry Maneuver', critical: true },
        { type: 'steps', intro: 'Spirogram shows:', items: [
          'Initial quiet breathing',
          'Maximal inspiration to TLC (total lung capacity)',
          'Rapid and complete forced expiration',
          'Steep descending curve',
          'FEV₁ marked at 1 second point',
          'Curve continues to residual volume'
        ]},
        { type: 'header', text: 'Key Spirometry Parameters', critical: true },
        { type: 'table', headers: ['Parameter', 'Definition', 'Normal Value'], rows: [
          ['FVC', 'Maximum volume expired after maximal inspiration', 'Variable (depends on size/sex)'],
          ['FEV₁', 'Volume expired in first 1 second', '~80% of FVC'],
          ['Tiffeneau Index', 'FEV₁/VC × 100', '75-80%'],
          ['PEF', 'Maximum flow rate during expiration', '10 L/s'],
          ['FEF₂₅₋₇₅', 'Average flow between 25-75% of FVC', 'Variable']
        ]},
        { type: 'formula', formula: 'Tiffeneau Index = (FEV₁ / VC) × 100', explanation: 'Evaluates degree of airway obstruction (normal: ≥70-80%)', critical: true },
        { type: 'paragraph', text: 'FVC: Total maximum volume expired after full inspiration with rapid, forceful, complete expiration' },
        { type: 'paragraph', text: 'FEV₁: Volume forcefully expired during the first second, marked at 1-second point on steep descending curve', critical: true },
        { type: 'paragraph', text: 'Tiffeneau Index: Ratio of FEV₁ to vital capacity. Normal: 75-80%. <70% indicates obstruction.', critical: true },
        { type: 'paragraph', text: 'PEF: Maximum flow rate achieved during forceful expiration after full inhalation. Measured in L/s (normal: 10 L/s). Reflects large airway function. Useful in asthma monitoring.' },
        { type: 'paragraph', text: 'FEF₂₅₋₇₅: Average flow rate during middle half of FVC maneuver (between 25% and 75% of FVC). Sensitive indicator of SMALL airway function. Can detect early obstruction even when FEV₁/VC appears normal.' },
        { type: 'comparison',
          left: {
            title: 'Obstructive Disease Pattern',
            items: [
              'Tiffeneau Index <70%',
              'FEV₁ disproportionately reduced',
              'FEF₂₅₋₇₅ reduced',
              'Examples: Asthma, COPD'
            ]
          },
          right: {
            title: 'Restrictive Disease Pattern',
            items: [
              'Tiffeneau Index normal or ↑',
              'Both FEV₁ and VC proportionally ↓',
              'FVC reduced',
              'Examples: Fibrosis, chest wall disease'
            ]
          }
        },
        { type: 'clinical', text: 'Clinical: PEF useful for home monitoring in asthma. FEF₂₅₋₇₅ detects small airway disease before FEV₁ changes.' }
      ]
    }
  }
};

export default topic26QuickReview;
